This company has shut down. Atrin Pharmaceuticals is no longer operating.
Explore the Startup GraveyardAtrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Atrin Pharmaceuticals's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, Keiretsu Capital, National Cancer Institute, Keiretsu Forum, Robin Hood Ventures.
Atrin Pharmaceuticals is headquartered in Doylestown, United States.
Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.
Atrin Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atrin Pharmaceuticals — Funding & Investors." VCBacked, July 2, 2022, https://www.vcbacked.co/company/atrin-pharmaceuticals. Accessed September 29, 2026.
VCBacked. (2022). Atrin Pharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/atrin-pharmaceuticals
{{cite web |title=Atrin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/atrin-pharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated